CDK12 and osteosarcoma: Furthermore, targeting CDK12 exhibited a significant decrease in the cellular proliferation of liver cancer via induction of DNA damage response17 and impaired osteosarcoma cell colonisation by downregulation of MYC proto‐oncogene (MYC).1